Morrisons One-A-Day Hayfever & Allergy Relief (Loratadine)

Loratadine blocks peripheral H1 histamine receptors, preventing histamine from binding and triggering the cascade that causes vasodilation, increased vascular permeability, and nerve irritation. By inhibiting this pathway, it reduces the early‑phase allergic response without significant penetration of the central nervous system.

The appropriate dose of Morrisons One-A-Day Hayfever & Allergy Relief is determined by a prescriber based on the patient’s age, weight, renal function and severity of symptoms. Patients should follow the healthcare professional’s instructions and not exceed the recommended amount.

Safety data for loratadine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Loratadine is a second‑generation H1 antagonist, offering effective allergy relief with a lower risk of sedation compared with first‑generation antihistamines such as diphenhydramine. Its longer half‑life allows once‑daily dosing, and it has fewer anticholinergic side effects, making it a preferred option for many patients.

Store Morrisons One-A-Day Hayfever & Allergy Relief at room temperature, below 25 °C. Keep the tablets in the original blister pack, protect them from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

The product is taken orally, typically with water. It can be taken with or without food. Patients should swallow the tablet whole and not crush or chew it unless otherwise directed by a healthcare professional.

Serious but rare risks include anaphylactic reactions, severe skin reactions such as Stevens‑Johnson syndrome, and significant liver enzyme elevations. Any signs of rash, swelling, difficulty breathing, or jaundice should prompt immediate medical evaluation.

Individuals with known hypersensitivity to loratadine or any of its excipients should not use the product. Caution is also advised for patients with severe renal impairment, and those taking medications that strongly inhibit CYP3A4, unless a prescriber determines it is appropriate.